| abstract |
The application relates to drug carrier particles that are suitable for tissue-specific drug application, especially for the central nervous system (CNS), and are present in drug-laden or drug-free form, at least one recognition protein being bound to the particle surface or the particle surface being modified such that upon contact with a recognition protein, it is bound to it. |